REBECCA A SOLOMON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DAVENPORT, IA NPI 1770133159
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IA Abbott Laboratories All categories
General Payments — all program years on this page
$8,011.99
- Category: General Payments
- Program years: PY2021–2024
- Record count: 356
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,607.65 across 77 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,002.40 | 4 |
| Food and Beverage | $1,605.25 | 73 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $2,247.07 | 7 |
| ABBVIE INC. | $283.34 | 20 |
| Lundbeck LLC | $161.93 | 7 |
| Biogen, Inc. | $140.76 | 4 |
| PFIZER INC. | $73.59 | 4 |
| Teva Pharmaceuticals USA, Inc. | $69.43 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.68 | 4 |
| Acerta Pharma LLC | $53.95 | 2 |
| Neurelis, Inc. | $42.17 | 2 |
| UCB, Inc. | $42.03 | 1 |
| JAZZ PHARMACEUTICALS INC. | $40.85 | 2 |
| Lilly USA, LLC | $31.23 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.93 | 1 |
| Octapharma USA, Inc. | $27.68 | 1 |
| Inspire Medical Systems, Inc. | $25.96 | 1 |
| CSL Behring | $24.62 | 1 |
| HARMONY BIOSCIENCES LLC | $24.62 | 2 |
| ARGENX US, INC. | $23.15 | 1 |
| Ipsen Biopharmaceuticals, Inc | $22.60 | 1 |
| Neurocrine BioSciences, Inc. | $22.26 | 1 |
| Axsome Therapeutics, Inc. | $21.92 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $21.33 | 1 |
| TONIX PHARMACEUTICALS, INC. | $18.68 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.56 | 1 |
| SK Life Science, Inc. | $17.30 | 1 |
| EISAI INC. | $17.27 | 1 |
| EMD Serono, Inc. | $14.53 | 1 |
| Celgene Corporation | $14.02 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.19 | 1 |
By program year
Records — PY2024 (77)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.